name:-0.17378807067871
name:-0.17573094367981
name:-0.00057792663574219
Aventis Pharmaceuticals Inc. Patent Filings

Aventis Pharmaceuticals Inc.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Aventis Pharmaceuticals Inc..The latest application filed is for "pharmaceutical composition comprising fexofenadine".

Company Profile
0.163.159
  • Aventis Pharmaceuticals Inc. - Bridgewater NJ
  • Aventis Pharmaceuticals Inc - Bridgewater NJ
  • Aventis Pharmaceuticals Inc. -
  • AVENTIS PHARMACEUTICALS INC. - 55 Corporate Boulevard Bridgewater NJ
  • AVENTIS PHARMACEUTICALS INC. - 300 Somerset Corporate Boulevard Bridgewater NJ
  • AVENTIS PHARMACEUTICALS INC. - 55 Corporate Drive Bridgewater NJ
  • AVENTIS PHARMACEUTICALS INC. - 300 Somerset Corporate Blvd. Bridgewater NJ
  • AVENTIS PHARMACEUTICALS INC. - 1041 Route 202-206 US 08807
  • Aventis Pharmaceuticals, Inc. - South San Francisco CA
  • Aventis Pharmaceuticals Inc. - Bridgwater NJ
  • Aventis Pharmaceuticals Inc. - 300 Somerser Corporate Boulevard Bridgewater NJ
  • Aventis Pharmaceuticals Inc. - Route 202-206 Bridgewater NJ
  • Aventis Pharmaceuticals, Inc. - Kansas City MO
  • Aventis Pharmaceuticals Inc. - N/A
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks
Patent Activity
PatentDate
Substituted propane phosphinic acid derivatives
Grant 8,828,974 - Choi-Sledeski , et al. September 9, 2
2014-09-09
Method for reducing cardiovascular morbidity and mortality in prediaetic patients and patients with type 2 diabetes
Grant 8,809,270 - Rosskamp , et al. August 19, 2
2014-08-19
Pharmaceutical Composition Comprising Fexofenadine
App 20140073670 - BADABHAGNI; Sudhakara Rao ;   et al.
2014-03-13
Nuclear factor .kappa.B inducing factor
Grant 8,642,739 - Denefle , et al. February 4, 2
2014-02-04
Nuclear factor .kappa.B inducing factor
Grant 8,623,831 - Denefle , et al. January 7, 2
2014-01-07
Method For Reducing Cardiovascular Morbidity And Mortality In Prediaetic Patients And Patients With Type 2 Diabetes
App 20130012433 - ROSSKAMP; Ralf ;   et al.
2013-01-10
Substituted Pyrimidines As Prostaglandin D2 Receptor Antagonists
App 20130005728 - HARRIS; Keith J. ;   et al.
2013-01-03
Substituted Pyrimidine As A Prostaglandin D2 Receptor Antagonist
App 20130005741 - HARRIS; Keith John ;   et al.
2013-01-03
Antibodies against LLG polypeptides of the triacylglycerol lipase family
Grant 8,343,494 - Jaye , et al. January 1, 2
2013-01-01
Benzimidazoles
Grant 8,288,425 - Edwards , et al. October 16, 2
2012-10-16
Substituted Propane Phosphinic Acid Derivatives
App 20120208784 - CHOI-SLEDESKI; Yong Mi ;   et al.
2012-08-16
Substituted Pyridones As Inhibitors Of Poly(adp-ribose) Polymerase (parp)
App 20120202795 - WEINTRAUB; Philip M. ;   et al.
2012-08-09
Pyrimidine amide compounds as PGDS inhibitors
Grant 8,202,863 - Aldous , et al. June 19, 2
2012-06-19
2,6-substituted-4-monosubstitutedamino-pyrimidine as prostaglandin D2 receptor antagonists
Grant 8,193,183 - Lim , et al. June 5, 2
2012-06-05
Substituted propane phosphinic acid derivatives
Grant 8,183,231 - Choi-Sledeski , et al. May 22, 2
2012-05-22
Antibodies Against LLG Polypeptides of the Triacylglycerol Lipase Family
App 20120114660 - Jaye; Michael C. ;   et al.
2012-05-10
Substituted pyridones as inhibitors of poly(ADP-ribose) polymerase (PARP)
Grant 8,173,682 - Weintraub , et al. May 8, 2
2012-05-08
Akt Nucleic Acids, Polypeptides, and Uses Thereof
App 20120034188 - Guo; Kun ;   et al.
2012-02-09
Method For Reducing Cardiovascular Morbidity And Mortality In Prediabetic Patients And Patients With Type 2 Diabetes
App 20110281793 - Rosskamp; Ralf ;   et al.
2011-11-17
Dipyrazole compounds and their use as central nervous system agents
Grant 8,053,458 - Kosley , et al. November 8, 2
2011-11-08
NUCLEAR FACTOR kappaB INDUCING FACTOR
App 20110263831 - KAPLOW; June ;   et al.
2011-10-27
NUCLEAR FACTOR kappaB INDUCING FACTOR
App 20110245471 - KAPLOW; June ;   et al.
2011-10-06
Aqueous-based Pharmaceutical Composition
App 20110230455 - KIM; Soo-Il
2011-09-22
Substituted AZA-indoles as inhibitors of poly(ADP-ribose) polymerase (PARP)
Grant 8,008,491 - Jiang , et al. August 30, 2
2011-08-30
3-arylthioindole-2-carboxamide derivatives and analogs thereof as inhibitors of casein kinase I
Grant 8,008,340 - Metz, Jr. August 30, 2
2011-08-30
AKT nucleic acids, polypeptides, and uses thereof
Grant 7,989,584 - Guo , et al. August 2, 2
2011-08-02
Method for reducing cardiovascular morbidity and mortality in prediabetic patients and patients with type 2 diabetes
Grant 7,977,310 - Rosskamp , et al. July 12, 2
2011-07-12
Aqueous-based pharmaceutical composition
Grant 7,977,045 - Kim July 12, 2
2011-07-12
Nuclear factor .kappa.B inducing factor
Grant 7,972,844 - Kaplow , et al. July 5, 2
2011-07-05
1-aroyl-piperidinyl benzamidines
Grant 7,947,684 - Pauls , et al. May 24, 2
2011-05-24
Azaindoles for inhibiting aurora2 and other kinases
Grant 7,943,616 - Cox , et al. May 17, 2
2011-05-17
Thienopyrazoles
Grant 7,928,231 - Jurcak , et al. April 19, 2
2011-04-19
3-substituted-5- and 6-aminoalkyl indole-2-carboxylic acid amides and related analogs as inhibitors of casein kinase I
Grant 7,923,466 - Metz, Jr. , et al. April 12, 2
2011-04-12
3-piperidinylisochroman-5-ols as dopamine agonists
Grant 7,919,508 - Shutske , et al. April 5, 2
2011-04-05
Retroviral vectors for delivery of interfering RNA
Grant 7,884,200 - Grueneberg , et al. February 8, 2
2011-02-08
N-sulfonylpipecolic acid derivative FKBP binding composition and pharmaceutical use thereof
Grant 7,777,042 - Kosley, Jr. , et al. August 17, 2
2010-08-17
Heterocyclic substituted carbonyl derivatives and their use as dopamine D.sub.3 receptor ligands
Grant 7,772,252 - Hendrix , et al. August 10, 2
2010-08-10
Method for analyzing continuous glucose monitoring data
Grant H2,246 - Miller , et al. August 3, 2
2010-08-03
Membrane penetrating peptides and uses thereof
Grant 7,754,678 - Guo , et al. July 13, 2
2010-07-13
Heterocyclic compounds as P2X7 ion channel blockers
Grant 7,741,493 - Shum , et al. June 22, 2
2010-06-22
Nucleic Acid Encoding A Novel Dp Receptor Protein And Methods Of Use Thereof
App 20100152427 - PARKAR; Ashfaq ;   et al.
2010-06-17
Akt Nucleic Acids, Polypeptides, And Uses Thereof
App 20100143308 - GUO; Kun ;   et al.
2010-06-10
Nucleic acid molecules encoding prostaglandin receptor proteins
Grant 7,723,074 - Parkar , et al. May 25, 2
2010-05-25
Substituted propane phosphinic acid esters
Grant 7,687,540 - Collis , et al. March 30, 2
2010-03-30
Thienopyrazoles
App 20100056514 - JURCAK; John Gerard ;   et al.
2010-03-04
Human Akt3 nucleic acid and uses thereof
Grant 7,662,628 - Guo , et al. February 16, 2
2010-02-16
Retroviral Vectors For Delivery Of Interfering Rna
App 20100028996 - GRUENEBERG; Dorre ;   et al.
2010-02-04
Pharmaceutical Composition For Piperidinoalkanol Compounds
App 20100021547 - ORTYL; Thomas T. ;   et al.
2010-01-28
Substituted thienopyrrole carboxylic acid amides, pyrrolothiazole carboxylic acid amides, and related analogs as inhibitors of casein kinase I
Grant 7,652,046 - Fink , et al. January 26, 2
2010-01-26
Dihydrogen phosphate salt of a prostaglandin D2 receptor antagonist
Grant 7,642,249 - Langevin , et al. January 5, 2
2010-01-05
1, 3, 4-oxadiazol-2-ones as peroxisome-proliferator activated receptor delta modulators and their use in the treatment of neurological and metabolic disease
Grant 7,638,539 - McGarry , et al. December 29, 2
2009-12-29
3-substituted-5- and 6-aminoalkyl indole-2-carboxylic acid amides and related analogs as inhibitors of casein kinase I
Grant 7,629,376 - Metz, Jr. , et al. December 8, 2
2009-12-08
Substituted bis aryl and heteroaryl compounds as selective 5HT.sub.2A antagonists
Grant 7,625,889 - Eastwood , et al. December 1, 2
2009-12-01
Substituted 1H-pyrrolo[2,3-c]pyridine-2-carboxamides and related analogs as inhibitors of casein kinase I.epsilon.
Grant 7,626,027 - Metz, Jr. , et al. December 1, 2
2009-12-01
Combination of a hypnotic agent and substituted bis aryl and heteroaryl compound and therapeutic application thereof
Grant 7,618,650 - Emmons , et al. November 17, 2
2009-11-17
Method Of Treating Of Demyelinating Diseases Or Conditions
App 20090281147 - SMITH; Craig P. ;   et al.
2009-11-12
1, 3, 4-oxadiazol-2-ones As Ppar Delta Modulators And Their Use Thereof
App 20090275621 - MCGARRY; Daniel G. ;   et al.
2009-11-05
Substituted oxoazaheterocyclyl compounds
Grant 7,612,075 - Ewing , et al. November 3, 2
2009-11-03
Retroviral vectors for delivery of interfering RNA
Grant 7,612,195 - Grueneberg , et al. November 3, 2
2009-11-03
Method Of Treating Of Demyelinating Diseases Or Conditions
App 20090270458 - SMITH; Craig P. ;   et al.
2009-10-29
Novel Heterocyclic Substituted Carbonyl Derivatives and Their Use as Dopamine D3 Receptor Ligands
App 20090247509 - Hendrix; James A. ;   et al.
2009-10-01
Method For Measuring Resistance Or Sensitivity To Docetaxel
App 20090226894 - Grueneberg; Dorre ;   et al.
2009-09-10
Antibodies against LLG polypeptides of the triacylglycerol lipase family
Grant 7,579,447 - Jaye , et al. August 25, 2
2009-08-25
Method Of Treating Of Demyelinating Diseases Or Conditions
App 20090209594 - SMITH; Craig P. ;   et al.
2009-08-20
Method Of Treating Of Demyelinating Diseases Or Conditions
App 20090209595 - SMITH; Craig P. ;   et al.
2009-08-20
1,3,4-oxadiazol-2-ones as PPAR delta modulators and their use thereof
Grant 7,576,109 - McGarry , et al. August 18, 2
2009-08-18
Nucleic Acid Encoding A Novel Prostaglandin Receptor Protein And Methods Of Use Thereof
App 20090178151 - PARKAR; Ashfaq ;   et al.
2009-07-09
Furosemide modulators of HM74
Grant 7,556,931 - Minnich , et al. July 7, 2
2009-07-07
Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases
Grant 7,550,597 - Myers , et al. June 23, 2
2009-06-23
Heterocyclic amide derivatives and their use as dopamine D3 receptor ligands
Grant 7,550,469 - Hendrix , et al. June 23, 2
2009-06-23
Pyrazoles as inhibitors of tumor necrosis factor
Grant 7,541,368 - Borcherding , et al. June 2, 2
2009-06-02
Coumarins as iNOS inhibitors
Grant 7,538,233 - Jackson , et al. May 26, 2
2009-05-26
Application of 2-cyano-10- (2-methyl-3- (methylamino)- propyl) phenothiazine or a pharmaceutically acceptable salt as medicament
Grant 7,538,106 - Dib , et al. May 26, 2
2009-05-26
Method of treating demyelinating diseases or conditions
Grant 7,534,803 - Smith , et al. May 19, 2
2009-05-19
Heterocyclic substituted carbonyl derivatives and their use as dopamine D.sub.3 receptor ligands
Grant 7,521,445 - Hendrix , et al. April 21, 2
2009-04-21
2,6-substituted-4-monosubstitutedamino-pyrimidine as prostaglandin D2 receptor antagonists
Grant 7,517,889 - Harris , et al. April 14, 2
2009-04-14
Thienopyrazoles
Grant 7,518,000 - Jurcak , et al. April 14, 2
2009-04-14
3-substituted-5- And 6-aminoalkyl Indole-2-carboxylic Acid Amides And Related Analogs As Inhibitors Of Casein Kinase I
App 20090082340 - METZ, JR.; William Arthur ;   et al.
2009-03-26
Prostaglandin receptor protein
Grant 7,488,799 - Parkar , et al. February 10, 2
2009-02-10
Compounds and compositions as cathepsin inhibitors
Grant 7,482,448 - Thurairatnam , et al. January 27, 2
2009-01-27
Automated Semi-solid Matrix Assay And Liquid Handler Apparatus For The Same
App 20080293090 - POWERS; Elaine
2008-11-27
Method For Reducing Cardiovascular Morbidity And Mortality In Prediabetic Patients And Patients With Type 2 Diabetes
App 20080287343 - ROSSKAMP; Ralf ;   et al.
2008-11-20
Apparatus And Method For Use In Solid Phase Chemical Synthesis
App 20080280784 - Guiles; Joseph W. ;   et al.
2008-11-13
Substituted Aza-indoles As Inhibitors Of Poly(adp-ribose) Polymerase (parp)
App 20080255350 - JIANG; John Z. ;   et al.
2008-10-16
G protein-coupled receptor, GAVE10
Grant 7,432,361 - Eishingdrelo , et al. October 7, 2
2008-10-07
Multi-dose erythropoietin formulations
Grant 7,432,360 - Gayed October 7, 2
2008-10-07
Acyl and sulfonyl derivatives of 6,9-disubstituted 2-(trans-1,4-diaminocyclohexyl)-purines and their use as antiproliferative agents
Grant 7,429,595 - Borcherding , et al. September 30, 2
2008-09-30
Pyrimidine Amide Compounds As Pgds Inhibitors
App 20080227782 - Aldous; Suzanne C. ;   et al.
2008-09-18
Use of a CB1 Antagonist for Treating Side Effects and Negative Symptoms of Schizophrenia
App 20080221078 - BLACK; Mark ;   et al.
2008-09-11
SUBSTITUTED 1H-PYRROLO[3,2-b, 3,2-c, and 2,3-c]PYRIDINE-2-CARBOXAMIDES AND RELATED ANALOGS AS INHIBITORS OF CASEIN KINASE Ie
App 20080200496 - METZ; William A. ;   et al.
2008-08-21
Dihydrogen Phosphate Salt Of A Prostaglandin D2 Receptor Antagonist
App 20080194600 - LANGEVIN; Beverly ;   et al.
2008-08-14
Method for reducing cardiovascular morbidity and mortality in prediabetic patients and patients with type 2 diabetes
Grant 7,405,196 - Rosskamp , et al. July 29, 2
2008-07-29
Substituted 1H-pyrrolo[3,2-b, 3,2-c, and 2,3-c]pyridine-2-carboxamides and related analogs as inhibitors of casein kinase lepsilon
Grant 7,402,672 - Metz, Jr. , et al. July 22, 2
2008-07-22
Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof
App 20080167471 - Henton; Daniel R. ;   et al.
2008-07-10
Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof
App 20080167469 - Henton; Daniel R. ;   et al.
2008-07-10
Substituted thienopyrrole carboxylic acid amides, pyrrolothiazole carboxylic acid amides, and related analogs as inhibitors of casein kinase I
Grant 7,393,867 - Fink , et al. July 1, 2
2008-07-01
Substituted sulfonamides and ureas useful for inhibiting kinase activity
Grant 7,393,849 - Safar , et al. July 1, 2
2008-07-01
Fkbp Binding Composition And Pharmaceutical Use Thereof
App 20080139556 - KOSLEY; Raymond W. ;   et al.
2008-06-12
Combination Of A Hypnotic Agent And R (+)-alpha-(2,3-dimethoxy-phenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidine- Methanol And Therapeutic Application Thereof
App 20080139615 - EMMONS; Gary T. ;   et al.
2008-06-12
Combination Of A Hypnotic Agent And Substituted Bis Aryl And Heteroaryl Compound And Therapeutic Application Thereof
App 20080138413 - EMMONS; Gary T. ;   et al.
2008-06-12
Heterocyclic Compounds As P2x7 Ion Channel Blockers
App 20080132550 - SHUM; Patrick ;   et al.
2008-06-05
Interleukin-4 Gene Expression Inhibitors
App 20080132481 - ALKAN; Sefik S. ;   et al.
2008-06-05
N-acylpyrrolidin-2-ylalkylbenzamidine derivatives as inhibitors of factor Xa
Grant 7,361,663 - Czekaj , et al. April 22, 2
2008-04-22
Dipyrazole Compounds And Their Use As Central Nervous System Agents
App 20080090872 - KOSLEY; Raymond W. ;   et al.
2008-04-17
Treating Acute Exacerbations Of Asthma Using A Ketolide
App 20080070846 - Nieman; Richard B. ;   et al.
2008-03-20
Oxydecahydronaphthalene Modulators Of Hm74
App 20080045586 - MINNICH; Anne ;   et al.
2008-02-21
Methods For The Treatment Of Multiple Sclerosis
App 20080033005 - MERRILL; Jean E. ;   et al.
2008-02-07
Antibiotic Compounds, Compositions And Methods Of Treatment
App 20080033031 - DEVLIN; Brid ;   et al.
2008-02-07
Heterocyclic compounds as P2X7 ion channel blockers
Grant 7,326,792 - Shum , et al. February 5, 2
2008-02-05
3-substituted-5- And 6-aminoalkyl Indole-2-carboxylic Acid Amides And Related Analogs As Inhibitors Of Casein Kinase I
App 20080027124 - METZ; William Arthur JR. ;   et al.
2008-01-31
Dosing Regimen of Flavopiridol for Treating Cancer`
App 20080027105 - SUAREZ; Jose-Ramon ;   et al.
2008-01-31
Substituted sulfonamides and ureas useful for inhibiting kinase activity
Grant 7,323,457 - Safar , et al. January 29, 2
2008-01-29
Nucleic Acid Encoding A Novel Prostaglandin Receptor Protein And Methods Of Use Thereof
App 20080020403 - Parkar; Ashfaq ;   et al.
2008-01-24
Methods Of Treating Demyelinating Disorders
App 20070280885 - Chandross; Karen ;   et al.
2007-12-06
Substituted Propane Phosphinic Acid Esters
App 20070270385 - COLLIS; Alan John ;   et al.
2007-11-22
Substituted Bis Aryl And Heteroaryl Compounds As Selective 5ht2a Antagonists
App 20070265309 - EASTWOOD; Paul Robert ;   et al.
2007-11-15
Novel Processes For The Preparation Of (r)-alpha-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinem- Ethanol
App 20070265450 - Hilpert; Thomas Heinz Eduard ;   et al.
2007-11-15
2-phenyl-indoles As Prostaglandin D2 Receptor Antagonists
App 20070265278 - HARRIS; Keith J. ;   et al.
2007-11-15
2,6-substituted-4-monosubstitutedamino-pyrimidine As Prostaglandin D2 Receptor Antagonists
App 20070265291 - HARRIS; Keith John ;   et al.
2007-11-15
Methods for Determining the Potency, Specificity, and Toxicity of Hematopoietic Prostaglandin D2 Synthase
App 20070259384 - Cao; Yang ;   et al.
2007-11-08
Thienopyrazoles
App 20070254937 - Jurcak; John Gerald ;   et al.
2007-11-01
Use Of Certain Biphenyl Compounds For Protection Of Neurons And Oligodendrocytes In The Treatment Of Multiple Sclerosis (ms)
App 20070249706 - MERRILL; Jean ;   et al.
2007-10-25
Use Of Certain Phenyl Napthyl Compounds For Protection Of Neurons And Oligodendrocytes In The Treatment Of Multiple Sclerosis (ms)
App 20070249732 - MERRILL; Jean ;   et al.
2007-10-25
Pharmaceutical Composition For Piperidinoalkanol Compounds
App 20070249671 - ORTYL; Thomas T. ;   et al.
2007-10-25
2,6-substituted-4-monosubstitutedamino-pyrimidine As Prostaglandin D2 Receptor Antagonists
App 20070244131 - Lim; Sungtaek ;   et al.
2007-10-18
Use Of Certain Phenyl-naphthyl Compounds That Do Not Have Significant Affinity To Er Alpha Or Er Beta For Protection Of Neurons And Oligodendrocytes In The Treatment Of Multiple Sclerosis
App 20070225330 - MERRILL; Jean E. ;   et al.
2007-09-27
Furosemide Modulators Of Hm74
App 20070213391 - MINNICH; Ann ;   et al.
2007-09-13
Substituted Sulfonamides And Ureas Useful For Inhibiting Kinase Activity
App 20070208008 - SAFAR; Pavel ;   et al.
2007-09-06
Oxydecahydronaphthalene modulators of HM74
Grant 7,264,937 - Minnich , et al. September 4, 2
2007-09-04
Novel Compounds and Compositions as Cathepsin S Inhibitors
App 20070203138 - Li; Jiayo ;   et al.
2007-08-30
Use Of (z)-2-cyano-3-hydroxy-but-2-enoic Acid-(4'-trifluoromethylphenyl)-amide For Treating Inflammatory Bowel Disease
App 20070197643 - SCHEYER; Richard D. ;   et al.
2007-08-23
Pyrrolopyrimidines
Grant 7,259,154 - Cox , et al. August 21, 2
2007-08-21
Substituted Sulfonamides And Ureas Useful For Inhibiting Kinase Activity
App 20070191347 - SAFAR; Pavel ;   et al.
2007-08-16
Extension Of The Expression of Transgenic Proteins By Immunomodulation
App 20070191299 - Seeman; Gerhard ;   et al.
2007-08-16
Benzisoxazolyl-, pyridoisoxazolyl-and benzthienyl-phenoxy derivatives useful as D.sub.4 antagonists
Grant 7,253,165 - Shutske , et al. August 7, 2
2007-08-07
Human Analogs Of Murine Deubiquitinating Protease
App 20070166297 - Hahn; Chang ;   et al.
2007-07-19
Novel heterocyclic substituted carbonyl derivatives and their use as dopamine D3 receptor ligands
App 20070161641 - Hendrix; James A. ;   et al.
2007-07-12
Use of cathepsin z inhibitors for the treatment of rhuematoid arthritis and other autoimmune diseases
App 20070155650 - Saltzman; Alan G. ;   et al.
2007-07-05
Use Of Peroxisome Proliferator Activated Receptor Delta Agonists For The Treatment Of Ms And Other Demyelinating Diseases
App 20070149580 - CHANDROSS; Karen ;   et al.
2007-06-28
3-arylthioindole-2-carboxamide Derivatives And Analogs Thereof As Inhibitors Of Casein Kinase I
App 20070142454 - METZ; William Arthur Jr.
2007-06-21
Novel heterocyclic amide derivatives and their use as dopamine D3 receptor ligands
App 20070142351 - Hendrix; James A. ;   et al.
2007-06-21
Substantially Pure 2-{[2-(2-Methylamino-Pyrimidin-4-YL)-1H-Indole-5-Carbonyl]-Amino}-3-Pheny- lpyridin-2-YL-Amino)-Propionic Acid as an IkB Kinase Inhibitor
App 20070142417 - HADDAD; El-Bdaoui ;   et al.
2007-06-21
[4-(5-Aminomethyl-2-fluoro-phenyl)-piperidin-1-yl]-(4-bromo-3-methyl-5-pro- poxy-thiophen-2-yl)-methanone hydrochloride as an inhibitor of mast cell tryptase
App 20070142435 - Gao; Zhongli ;   et al.
2007-06-21
Furosemide modulators of HM74
Grant 7,232,811 - Minnich , et al. June 19, 2
2007-06-19
Novel Compounds and Compositions as Cathepsin Inhibitors
App 20070135386 - Graupe; Michael ;   et al.
2007-06-14
Transposon mediated multiplex sequencing
Grant 7,229,798 - August , et al. June 12, 2
2007-06-12
Method of treating of demyelinating diseases or conditions
Grant 7,230,015 - Smith , et al. June 12, 2
2007-06-12
Processes For Preparing Anhydrous And Hydrate Forms Of Antihistaminic Piperidine Derivatives, Polymorphs And Pseudomorphs Thereof
App 20070129401 - HENTON; Daniel R. ;   et al.
2007-06-07
Secreted neural apoptosis inhibiting proteins
App 20070128667 - Merrill; Jean ;   et al.
2007-06-07
Method Of Treating Schizophrenia And/or Glucoregulatory Abnormalities
App 20070129403 - Smith; Craig P. ;   et al.
2007-06-07
Compounds and compositions as cathepsin S inhibitors
Grant 7,226,921 - Li , et al. June 5, 2
2007-06-05
Substituted sulfonamides and ureas useful for inhibiting kinase activity
Grant 7,223,763 - Safar , et al. May 29, 2
2007-05-29
1, 3, 4-oxadiazol-2-ones As Peroxisome-proliferator Activated Receptor Delta Modulators And Their Use In The Treatment Of Neurological And Metabolic Disease
App 20070099964 - McGarry; Daniel G. ;   et al.
2007-05-03
3-piperidinylisochroman-5-ols As Dopamine Agonists
App 20070099955 - Shutske; Gregory ;   et al.
2007-05-03
Human analogs of murine deubiquitinating proteases
Grant 7,202,073 - Hahn , et al. April 10, 2
2007-04-10
Compounds and compositions as cathepsin inhibitors
Grant 7,196,099 - Graupe , et al. March 27, 2
2007-03-27
1,3,4-oxadiazol-2-ones As Ppar Delta Modulators And Their Use Thereof
App 20070060626 - MCGARRY; Daniel G. ;   et al.
2007-03-15
Substituted Propane Phosphinic Acid Derivatives
App 20070060502 - Choi-Sledeski; Yong Mi ;   et al.
2007-03-15
Process for the preparation of 3-amino-2-hydroxypropylphosphinic acid derivatives
Grant 7,186,705 - Huang , et al. March 6, 2
2007-03-06
Heterocyclic substituted carbonyl derivatives and their use as dopamine D.sub.3 receptor ligands
Grant 7,186,724 - Hendrix , et al. March 6, 2
2007-03-06
Novel compounds and compositions as cathepsin inhibitors
App 20070049594 - Graupe; Michael ;   et al.
2007-03-01
Prostaglandin receptor protein and methods of use thereof
Grant 7,183,062 - Parkar , et al. February 27, 2
2007-02-27
Human deubiquitinating protease gene on chromosome 7 and its murine ortholog
Grant 7,179,631 - Hahn , et al. February 20, 2
2007-02-20
Method of treating of demyelinating diseases or conditions
Grant 7,179,821 - Smith , et al. February 20, 2
2007-02-20
Substituted Pyridones As Inhibitors Of Poly(adp-ribose) Polymerase (parp)
App 20070032489 - Weintraub; Philip M. ;   et al.
2007-02-08
Indole derivatives as interleukin-4 gene expression inhibitors
Grant 7,169,925 - Merriman , et al. January 30, 2
2007-01-30
Processes For Preparing Anhydrous And Hydrate Forms Of Antihistaminic Piperidine Derivatives, Polymorphs And Pseudomorphs Thereof
App 20070021462 - Henton; Daniel R. ;   et al.
2007-01-25
Processes For Preparing Anhydrous And Hydrate Forms Of Antihistaminic Piperidine Derivatives, Polymorphs And Pseudomorphs Thereof
App 20070021461 - Henton; Daniel R. ;   et al.
2007-01-25
Thienoisoxazolyl-and Thienylpyrrazolyl Phenoxy Substituted Propyl Derivatives Useful As D4 Antagonists
App 20070004695 - Fink; David M. ;   et al.
2007-01-04
Administration of enoxaparin sodium to patients with severe renal impairment
Grant 7,157,445 - Sanderink , et al. January 2, 2
2007-01-02
Solid phase synthesis of n,n-disubstituted diazacycloalkylcarboxy derivatives
Grant 7,138,526 - Herpin , et al. November 21, 2
2006-11-21
Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof
Grant 7,138,524 - McCarty , et al. November 21, 2
2006-11-21
Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof
Grant 7,135,571 - Henton , et al. November 14, 2
2006-11-14
Retroviral vectors for delivery of interfering rna
App 20060252153 - Grueneberg; Dorre ;   et al.
2006-11-09
Pyrazoloisoquinoline derivative as kinase inhibitors for the treatment of various disorders
Grant 7,132,428 - Majid , et al. November 7, 2
2006-11-07
Use of (+)-.alpha.-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4- piperidinemethanol or its prodrug in the treatment of behavioral or psychological symptoms associated with a disease
Grant 7,132,433 - Scheyer , et al. November 7, 2
2006-11-07
Methods for determining the potency, specificity, and toxicity of microsomal prostaglandin E2 synthase
Grant 7,132,256 - Cao , et al. November 7, 2
2006-11-07
Thienoisoxazolyl-and thienylpyrrazolyl-phenoxy substituted propyl derivatives useful as D.sub.4 antagonists
Grant 7,125,903 - Fink , et al. October 24, 2
2006-10-24
Apparatus and method for synthesizing combinatorial libraries
Grant 7,122,323 - Patek , et al. October 17, 2
2006-10-17
Injectable Phosphatidylcholine Preparations
App 20060222673 - Chern; Wendy ;   et al.
2006-10-05
Process for the preparation of N-amino substituted heterocyclic compounds
Grant 7,112,682 - Weiberth , et al. September 26, 2
2006-09-26
Preserved pharmaceutical formulations
Grant 7,109,161 - Gayed September 19, 2
2006-09-19
Heteroarylpiperidines, and their use as antipsychotics and analgetics
Grant RE39,265 - Strupczewski , et al. September 5, 2
2006-09-05
Novel compounds and compositions as cathepsin inhibitors
App 20060189657 - Thurairatnam; Sukanthini ;   et al.
2006-08-24
Thienoisoxazole phenoxy unsubstituted ethyl and propyl derivatives useful as d.sub.4 antagonists
Grant 7,091,199 - Lee , et al. August 15, 2
2006-08-15
Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analgesics
Grant RE39,198 - Strupczewski , et al. July 18, 2
2006-07-18
Positive controls in polynucleotide amplification
Grant 7,070,962 - Ryncarz July 4, 2
2006-07-04
Process for preparing heteroaryl and unsaturated heterocycloalkylmagnesium reagents and uses thereof
App 20060135781 - Li; Jiayao ;   et al.
2006-06-22
Compounds and compositions as cathepsin inhibitors
Grant 7,064,123 - Graupe , et al. June 20, 2
2006-06-20
LLG polypeptides of the triacylglycerol lipase family, and compositions and methods for their use in enzymatic hydrolysis, and protein and gene therapies
Grant 7,056,720 - Jaye , et al. June 6, 2
2006-06-06
Gave10 agonists for treating inflammation
App 20060111331 - Eishingdrelo; Haifeng ;   et al.
2006-05-25
Membrane penetrating peptides and uses thereof
App 20060100134 - Guo; Yong ;   et al.
2006-05-11
Use of thiazolobenzoheterocycles for treating multiple sclerosis
Grant 7,041,661 - Zhu , et al. May 9, 2
2006-05-09
Compositions and methods for effecting the levels of high density lipoprotein (HDL) cholesterol and apolipoprotein Al, very low density lipoprotein (VLDL) cholesterol and low density lipoprotein (LDL) cholesterol
App 20060088504 - Jaye; Michael ;   et al.
2006-04-27
Novel compounds and compositions as cathepsin inhibitors
App 20060089357 - Graupe; Michael ;   et al.
2006-04-27
Crystalline forms of a factor Xa inhibitor
Grant 7,034,160 - Woodward , et al. April 25, 2
2006-04-25
Compounds and compositions as cathepsin inhibitors
Grant 7,030,116 - Graupe , et al. April 18, 2
2006-04-18
Endiandric acid H and its derivatives, process for their preparation and use thereof
Grant 7,019,028 - Eder , et al. March 28, 2
2006-03-28
Pyrazoles as inhibitors of tumor necrosis factor
App 20060063796 - Borcherding; David R. ;   et al.
2006-03-23
Compositions and methods for effecting the levels of high density lipoprotein (HDL) cholesterol and apolipoprotein AI very low density lipoprotein (VLDL) cholesterol and low density lipoprotein (LDL) cholesterol
Grant 7,008,776 - Jaye , et al. March 7, 2
2006-03-07
Use of an inhibitor of cathepsin-S-or-B to treat or prevent chronic obstructive pulmonary disease
App 20060030562 - Zheng; Tao ;   et al.
2006-02-09
Methods for determining the potency, specificity, and toxicity of microsomal prostaglandin E2 synthase
App 20060024663 - Cao; Yang ;   et al.
2006-02-02
Benzimidazoles
App 20060014756 - Edwards; Michael L. ;   et al.
2006-01-19
Method and system for marketing a treatment regimen
App 20050283386 - Powers, Joseph ;   et al.
2005-12-22
Compounds and compositions as cathepsin S inhibitors
Grant 6,977,256 - Li , et al. December 20, 2
2005-12-20
Chemical compounds
Grant 6,977,263 - Astles , et al. December 20, 2
2005-12-20
Use of R (+)-alpha-(2,3-dimethoxyphenyl)-1-[2-(4-flurophenyl)-ethyl]-4- piperidinemethanol for the treatment of sleep disorders and process for making pharmaceutical composition
App 20050272773 - Mondadori, Cesar ;   et al.
2005-12-08
Novel compounds and compositions as cathepsin S inhibitors
App 20050267044 - Li, Jiayo ;   et al.
2005-12-01
Azaindoles
App 20050267304 - Cox, Paul J. ;   et al.
2005-12-01
Novel processes for the preparation of (R)-alpha-(2,3-dimethoxyphenyl)-1-[- 2-(4-fluorophenyl)ethyl]-4-piperidinemethanol
App 20050261341 - Laux, Wolfgang ;   et al.
2005-11-24
Method of treating of demyelinating diseases or conditions
Grant 6,967,210 - Smith , et al. November 22, 2
2005-11-22
Novel 4-diphenylmethyl piperidine derivatives
App 20050239834 - Ling, Kah Hiing ;   et al.
2005-10-27
Method of treating of demyelinating diseases or conditions
App 20050234105 - Smith, Craig P. ;   et al.
2005-10-20
Chemical compounds
App 20050228018 - Astles, Peter C. ;   et al.
2005-10-13
3-mercaptoacetylamino-1,5-substituted-2-oxo-azepan derivatives useful as inhibitors of matrix metalloproteinase
Grant 6,953,788 - Warshawsky , et al. October 11, 2
2005-10-11
Interactive electronic-desktop alert and compliance tool
App 20050197903 - Hoffman, Daniel ;   et al.
2005-09-08
Use of R (+)-.alpha.-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidine methanol for the treatment of substance induced insomnia
Grant 6,939,879 - Mondadori , et al. September 6, 2
2005-09-06
Furosemide modulators of HM74
App 20050187280 - Minnich, Anne ;   et al.
2005-08-25
Oxydecahydronaphthalene modulators of HM74
App 20050187263 - Minnich, Anne ;   et al.
2005-08-25
Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases
App 20050182054 - Myers, Michael R. ;   et al.
2005-08-18
Dissolution test sample holder
Grant 6,929,782 - Ciliberto , et al. August 16, 2
2005-08-16
Antihistaminic piperidine derivatives and intermediates for the preparation thereof
Grant 6,930,197 - Ayers August 16, 2
2005-08-16
Method of treating of demyelinating diseases or conditions
App 20050159456 - Smith, Craig P. ;   et al.
2005-07-21
Akt nucleic acids, polypeptides, and uses thereof
App 20050142603 - Guo, Kun ;   et al.
2005-06-30
Nucleic acid encoding a novel prostaglandin receptor protein and methods of use thereof
App 20050142558 - Parkar, Ashfaq ;   et al.
2005-06-30
Substituted 1H-pyrrolo[3,2-b, 3,2-c, and 2,3-c]pyridine-2-carboxamides and related analogs as inhibitors of casein kinase lepsilon
App 20050131012 - Metz, William A. JR. ;   et al.
2005-06-16
Azaindoles
Grant 6,897,207 - Cox , et al. May 24, 2
2005-05-24
Benzimidazoles
Grant 6,897,208 - Edwards , et al. May 24, 2
2005-05-24
Novel heterocyclic amide derivatives and their use as dopamine D3 receptor ligands
App 20050107389 - Hendrix, James A. ;   et al.
2005-05-19
AKT nucleic acids, polypeptides, and uses thereof
Grant 6,881,555 - Guo , et al. April 19, 2
2005-04-19
Process for the preparation of 3-amino-2-hydroxypropylphosphinic acid derivatives
App 20050070507 - Huang, Bao-Guo ;   et al.
2005-03-31
Three-dimensional array of supports for solid-phase parallel synthesis and method of use
Grant 6,872,535 - Baum March 29, 2
2005-03-29
Substituted indoles as inhibitors of poly (ADP-ribose) polymerase (PARP)
App 20050054631 - Jiang, John Z. ;   et al.
2005-03-10
Coumarins as iNOS inhibitors
App 20050054681 - Jackson, Sharon ;   et al.
2005-03-10
Acyl and sulfonyl derivatives of 6,9-disubstituted 2-(trans-1,4-diaminocyclohexyl)-purines and their use as antiproliferative agents
Grant 6,861,524 - Borcherding , et al. March 1, 2
2005-03-01
Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases
Grant 6,852,712 - Myers , et al. February 8, 2
2005-02-08
Heterocyclic compounds as P2X7 ion channel blockers
App 20050026916 - Shum, Patrick ;   et al.
2005-02-03
Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases
Grant 6,846,815 - Myers , et al. January 25, 2
2005-01-25
Pyrazoloisoquinoline derivative as kinase inhibitors for the treatment of various disorders
App 20050009859 - Majid, Tahir Nadeem ;   et al.
2005-01-13
Novel processes for the preparation of (R)-alpha-(2,3-dimethoxyphenyl)-1-[- 2-(4-fluorophenyl)ethyl]-4-piperidinemethanol
App 20050010051 - Evans, Jonathan C. ;   et al.
2005-01-13
Profile searching in nucleic acid sequences using the fast fourier transformation
Grant 6,842,703 - Newell January 11, 2
2005-01-11
Novel process for the preparation of form 1 ranitidine hydrochloride
App 20040267030 - Cheng, Wen J. ;   et al.
2004-12-30
Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and /or p56lck tyrosine kinases
Grant 6,821,962 - Myers , et al. November 23, 2
2004-11-23
Method for reducing cardiovascular morbidity and martality in prediabetic patients and patients with type 2 diabetes
App 20040229774 - Rosskamp, Ralf ;   et al.
2004-11-18
Vectors for improving cloning and expression in low copy number plasmids
Grant 6,818,441 - Grossman , et al. November 16, 2
2004-11-16
1-Aroyl-piperidinyl benzamidines
App 20040220171 - Pauls, Heinz ;   et al.
2004-11-04
Novel processes for the preparation of (R)-alpha-(2,3-dimethoxyphenyl)-1-[- 2-(4-fluorophenyl) ethyl]-4-piperidinemethanol
App 20040210061 - Hilpert, Thomas Heinz Eduard ;   et al.
2004-10-21
Use of (+)-alpha-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4- piperidinemethanol or its prodrug in the treatment of symptoms of dementia and dopamine induced psychosis
App 20040204457 - Scheyer, Richard D. ;   et al.
2004-10-14
Substituted sulfonamides and ureas useful for inhibiting kinase activity
App 20040204582 - Safar, Pavel ;   et al.
2004-10-14
Novel compounds and compositions as cathepsin inhibitors
App 20040192742 - Graupe, Michael ;   et al.
2004-09-30
4-(3-aminomethylphenyl)piperidin-1-yl]-[5-(2-fluorophenylethynyl)furan-2-y- l]-methanone as an inhibitor of mast cell tryptase
App 20040192734 - Pauls, Heinz W. ;   et al.
2004-09-30
Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides
Grant 6,797,700 - Klein , et al. September 28, 2
2004-09-28
Use of (Z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluoromethylphenyl)-amide for treating multiple sclerosis
Grant 6,794,410 - Wettstein September 21, 2
2004-09-21
Serotonin antagonists
App 20040176413 - Nieduzak, Thaddeus R. ;   et al.
2004-09-09
Application of 2-cyano-10- (2-methyl-3- (methylamino)- propyl) phenothiazine or a pharmaceutically acceptable salt as medicament
App 20040171610 - Dib, Michel ;   et al.
2004-09-02
Novel 4-diphenylmethyl piperidine derivatives
App 20040167169 - Ling, Kah Hiing ;   et al.
2004-08-26
Substituted amides, sulfonamides and ureas useful for inhibiting kinase activity
Grant 6,777,577 - Safar , et al. August 17, 2
2004-08-17
Method of treating of demyelinating diseases or conditions
App 20040157888 - Smith, Craig P. ;   et al.
2004-08-12
Method of treating of demyelinating diseases or conditions
App 20040157889 - Smith, Craig P. ;   et al.
2004-08-12
Method for the isolation of sulfuric acid mono-[3({1-[2-(4-fluorophenyly)-- ethyl]-piperidin-4-yl}-2-methoxy-phenyl}ester
App 20040152900 - Bernotas, Ronald Charles ;   et al.
2004-08-05
1-Carboxylmethyl-2-oxo-azepan derivatives useful as selective inhibitors of MMP-12
Grant 6,770,640 - Warshawsky , et al. August 3, 2
2004-08-03
Use of Thiazolobenzoheterocycles for treating multiple sclerosis
App 20040147504 - Zhu, Bin ;   et al.
2004-07-29
Pyrrolopyrimidines
App 20040142947 - Cox, Paul Joseph ;   et al.
2004-07-22
Novel compounds and compositions as cathepsin inhibitors
App 20040142999 - Graupe, Michael ;   et al.
2004-07-22
Factor Xa inhibitors
Grant 6,759,384 - Al-Obeidi , et al. July 6, 2
2004-07-06
Timing curation of administration of adenosine A1/A2 agonist for cardioprotection
App 20040122045 - Xu, Zhelong ;   et al.
2004-06-24
STABLE NON-HYGROSCOPIC CRYSTALLINE FORM OF N-[N-[N-(4-(PIPERIDIN-4-YL)BUTANOYL)-N-ETHYLGLYCYL]ASPARTYL]-L-.beta.-CYCL OHEXYL ALANINE AMIDE, INTERMEDIATES THEREOF, AND PREPARATION THEREOF AND OF ANTITHROMBOTIC AZACYCLOALKYLALKANOYL PEPTIDES AND PSEUDOPEPTIDES
Grant 6,753,409 - Chrzan , et al. June 22, 2
2004-06-22
Method for assaying compounds that decrease the activity of poly (ADP-ribose)-Polymerase (PARP)
App 20040115710 - Li, Zhuyin Julie ;   et al.
2004-06-17
Preparative separation of mixtures by mass spectrometry
Grant 6,750,448 - Turecek , et al. June 15, 2
2004-06-15
Substituted oxoazaheterocyclyl compounds
App 20040102450 - Ewing, William R. ;   et al.
2004-05-27
Antihistaminic piperidine derivatives and intermediates for the preparation thereof
Grant 6,730,791 - Ayers May 4, 2
2004-05-04
Method for assaying compounds or agents for ability to decrease the activity of microsomal prostaglandin E synthase or hematopoietic prostaglandin D synthase
App 20040082021 - Li, Zhuyin ;   et al.
2004-04-29
Luciferase reporter bioassay of parathyroid hormone compounds
Grant 6,720,153 - Labaudiniere , et al. April 13, 2
2004-04-13
Unsaturated phosphonate derivatives of purines and pyrimidines
App 20040068111 - Casara, Patrick ;   et al.
2004-04-08
Piperididinyl and N-amidinopiperidinyl derivatives
App 20040067988 - Klein, Scott I. ;   et al.
2004-04-08
Sulfuric acid mono-[3-({1-[2-(4-fluoro-phenyl)-ethyl]-piperidin-4-YL}-hydroxy-methyl)-2- methoxy-phenyl]ester
Grant 6,716,986 - Bernotas , et al. April 6, 2
2004-04-06
Apparatus and method for use is solid phase chemical synthesis
App 20040062688 - Guiles, Joseph W. ;   et al.
2004-04-01
Processes for the preparation of (R)-.alpha.-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidine methanol
Grant 6,713,627 - Daugs , et al. March 30, 2
2004-03-30
Three-dimensional array of supports for solid-phase parallel synthesis and method of use
App 20040058391 - Baum, Stephen A.
2004-03-25
Process for the solid phase synthesis of aldehyde, ketone, oxime, amine, hydroxamic acid and .alpha.,.beta.-unsaturated carboxylic acid and aldehyde compounds
Grant 6,710,208 - Salvino , et al. March 23, 2
2004-03-23
Antihistaminic piperidine derivatives and intermediates for the preparation thereof
Grant 6,700,012 - Ayers March 2, 2
2004-03-02
Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases
Grant 6,696,434 - Myers , et al. February 24, 2
2004-02-24
Osteopontin, oligodendrocytes and myelination
App 20040033226 - Merrill, Jean ;   et al.
2004-02-19
Automated semi-solid matrix assay and liquid handler apparatus for the same
App 20040033554 - Powers, Elaine
2004-02-19
Elastase inhibitors
Grant 6,693,072 - Gallion , et al. February 17, 2
2004-02-17
Antihistaminic piperidine derivatives and intermediates for the preparation thereof
Grant 6,689,898 - Ayers February 10, 2
2004-02-10
Antihistaminic piperidine derivatives and intermediates for the preparation thereof
Grant 6,683,094 - Ayers , et al. January 27, 2
2004-01-27
Multi-well plate with perimeteral heat reservoir
Grant 6,676,905 - Al-Obeidi , et al. January 13, 2
2004-01-13
Human deubiquitinating protease gene on chromosome 7 and its murine ortholog
App 20040001820 - Hahn, Chang S. ;   et al.
2004-01-01
Use of R (+)-alpha-(2,3-Dimethoxyphenyl)-1-[2-(4-fluorophenyl) ethyl]-4-piperidinemethanol for the treatment of sleep disorders
App 20040002516 - Mondadori, Cesare ;   et al.
2004-01-01
Assays for .beta.-amyloid processing
Grant 6,670,182 - Pruss , et al. December 30, 2
2003-12-30
Novel G protein-coupled receptor, GAVE2
App 20030236194 - Eishingdrelo, Haifeng ;   et al.
2003-12-25
Use of riluzole in the treating acoustic traumas
Grant 6,660,757 - Stutzmann , et al. December 9, 2
2003-12-09
Human analogs of murine deubiquitinating protease genes
App 20030224969 - Hahn, Chang ;   et al.
2003-12-04
Novel crystalline forms of a factor Xa inhibitor
App 20030225144 - Woodward, Rick G. ;   et al.
2003-12-04
Adeno-associated viral liposomes and their use in transfecting dendritic cells to stimulate specific immunity
Grant 6,652,850 - Philip , et al. November 25, 2
2003-11-25
Aryl and heteroaryl quinazoline compounds which inhibit CSF-1R receptor tyrosine kinase
Grant 6,645,969 - Myers , et al. November 11, 2
2003-11-11
6,9-disubstituted 2-[trans-(4-aminocyclohexyl)amino] purines
Grant 6,642,231 - Dumont , et al. November 4, 2
2003-11-04
Fluorophenyl resin compounds
Grant 6,639,023 - Salvino , et al. October 28, 2
2003-10-28
Microarray-based subtractive hybridzation
Grant 6,638,717 - Perrin , et al. October 28, 2
2003-10-28
Use of R(+) -.alpha.-(2,3-Dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piper idinemethanol for the treatment of sleep disorders
Grant 6,613,779 - Mondadori , et al. September 2, 2
2003-09-02
DNA encoding human endothelial cell growth factors and plasmids comprising said DNA
Grant RE38,240 - Jaye , et al. August 26, 2
2003-08-26
Substituted (aminoiminomethyl or aminomethyl) benzoheteroaryl compounds
App 20030153604 - Dankulich, William P. ;   et al.
2003-08-14
Method and reagents for the quantification of solid-phase reactions using fluorine NMR
Grant 6,599,753 - Nagulapalli , et al. July 29, 2
2003-07-29
Substituted (aminoiminomethyl or aminomethyl) dihydrobenzofurans and benzopyrans
Grant 6,599,918 - Burns , et al. July 29, 2
2003-07-29
Pseudopolymorph of (--)-cis-2-(2-chlorophenyl)-5,7-dihydroxy-8[4R-(3S-hydroxy -1-methyl)piperidinyl]-4H-1-benzopyran-4-one
Grant 6,576,647 - Bafus , et al. June 10, 2
2003-06-10
Novel G Protein-coupled receptor, GAVE1
App 20030064434 - Ardati, Ali ;   et al.
2003-04-03
Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases
Grant 6,528,526 - Myers , et al. March 4, 2
2003-03-04
Transgenic rabbit that expresses a functional human lipoprotein (a)
Grant 6,512,161 - Rouy , et al. January 28, 2
2003-01-28
Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases
Grant 6,482,834 - Spada , et al. November 19, 2
2002-11-19
6, 9-disubstituted 2-[trans-(4-aminocyclohexyl)amino] purines
Grant 6,479,487 - Dumont , et al. November 12, 2
2002-11-12
Biodegradable polymer encapsulated pharmaceutical compositions and method for preparing the same
Grant 6,455,526 - Kohn , et al. September 24, 2
2002-09-24
Method of enhancing bioavailability of fexofenadine and its derivatives
Grant 6,451,815 - Hwang , et al. September 17, 2
2002-09-17
6,9,-disubstituted 2-[trans-(4-aminocyclohexyl) amino] purines
Grant 6,413,974 - Dumont , et al. July 2, 2
2002-07-02
LLG polypeptides of the triacylglycerol lipase family, and compositions and methods for their use in enzymatic hydrolysis, and protein and gene therapies
Grant 6,395,530 - Jaye , et al. May 28, 2
2002-05-28
Process for the solid phase synthesis of aldehyde, ketone, oxime, amine, hydroxamic acid and .alpha..beta.-unsaturated carboxylic acid and aldehyde compounds
Grant 6,392,010 - Salvino , et al. May 21, 2
2002-05-21
4-aza steroids
Grant 6,365,597 - Pribish , et al. April 2, 2
2002-04-02
1-(arylthioalkyl, arylaminoalkyl, or arylmethylenealkyl)-4-(heteroaryl)piperazines and related compounds useful as antipsychotics and analgesics
Grant RE37,478 - Strupczewski , et al. December 18, 2
2001-12-18
Substituted 4-(1H-benzimidazol-2-yl-amino)piperidines useful for the treatment of allergic diseases
Grant 6,211,199 - Kane , et al. April 3, 2
2001-04-03
1-(aryloxyalkyl)-4-(heteroaryl)piperidines and related compounds useful as antipsychotics and analgesics
Grant 6,140,345 - Strupczewski , et al. October 31, 2
2000-10-31
Pharmaceutical composition for piperidinoalkanol compounds
Grant 6,113,942 - Ortyl , et al. September 5, 2
2000-09-05
Company Registrations

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed